Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 14, 2014 - Issue 10
Submit an article Journal homepage
341
Views
6
CrossRef citations to date
0
Altmetric
Drug Profiles

Transdermal rivastigmine in the treatment of Alzheimer’s disease: current and future directions

Hamid Reza AmanatkarCorrespondence[email protected]
&
George Thomas GrossbergDepartment of Neurology and Psychiatry, School of Medicine, Saint Louis University, St. Louis, MO, USA
Pages 1119-1125 | Published online: 09 Sep 2014

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Sirasa Ruangritchankul, Prawat Chantharit, Sahaphume Srisuma & Leonard C Gray. (2021) Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review. Therapeutics and Clinical Risk Management 17, pages 927-949.
Read now
Daniela Galimberti & Elio Scarpini. (2017) Pioglitazone for the treatment of Alzheimer’s disease. Expert Opinion on Investigational Drugs 26:1, pages 97-101.
Read now
Daniela Galimberti & Elio Scarpini. (2015) Idalopirdine as a treatment for Alzheimer’s disease. Expert Opinion on Investigational Drugs 24:7, pages 981-987.
Read now

Articles from other publishers (3)

Yu Cai, Qi Tian, Chao Liu & Liang Fang. (2021) Development of long-acting rivastigmine drug-in-adhesive patch utilizing ion-pair strategy and characterization of controlled release mechanism. European Journal of Pharmaceutical Sciences 161, pages 105774.
Crossref
Vassileios Vagenas, Georgios S Vlachos, Nikoleta Vlachou, Dimitrios Liakopoulos, Michail E Kalaitzakis & Michail Vikelis. (2015) A prospective non-interventional study for evaluation of quality of life in patients with Alzheimer’s disease treated with rivastigmine transdermal patch. SAGE Open Medicine 3, pages 205031211558779.
Crossref
Florindo Stella, Márcia Radanovic, Paulo Renato Canineu, Vanessa J. R. de Paula & Orestes V. Forlenza. (2015) Anti-dementia medications: current prescriptions in clinical practice and new agents in progress. Therapeutic Advances in Drug Safety 6:4, pages 151-165.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.